DERM has been bouncing off this trendline since April and it doesn't have a reason to fail now with an ER beat which was the first beat in the last. Great Risk / Reward setup here to get back up to 12.00 dollars and if we get that 200 MA break we can shoot back up to 20 dollars easy with FDA approval and more sales number coming in next ER as this was just approved.